Characterizing cancers by prevalence on the PD-L1/CD8 axis

被引：0
作者：
Schmidt, Guenter [1 ]
Steele, Keith [2 ]
Meier, Armin [1 ]
Herz, Thomas [1 ]
Tan, Tze Heng [1 ]
Higgs, Brandon [2 ]
Althammer, Sonja [1 ]
Huss, Ralf [1 ]
机构：
[1] Definiens AG, Munich, Germany
[2] MedImmune LLC, Gaithersburg, MD USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P83
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Correlation of CD8 infiltration and expression of its checkpoint proteins PD-L1 and PD-L2 with the stage of cervical carcinoma
    Carvalho, Maria O. O.
    Nicol, Alcina F.
    Oliveira, Nathalia S.
    Cunha, Cynthia B.
    Amaro-Filho, Sergio M.
    Russomano, Fabio B.
    Portari, Elizabeth A.
    Nuovo, Gerard J.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10406 - 10413
  • [42] PD-L1 blockade restores function to CD8 T cells during chronic viral infection
    Barber, DL
    Wherry, EJ
    Masopust, D
    Greenwald, RJ
    Sharpe, AH
    Freeman, GJ
    Ahmed, R
    FASEB JOURNAL, 2005, 19 (04) : A893 - A893
  • [43] PD-L1 and CD8 IHC dual assessment in NSCLC using the Halioseek® assay: A multicentric study
    Batista, Luciana
    Brandone, Nicolas
    Garcia, Stephane
    Boumber, Yanis
    Dulaimi, Essel
    Taniere, Philippe
    Hofman, Paul
    Ilie, Marius
    Adam, Julien
    Galon, Jerome
    Gerbon, Catherine
    Fieschi, Jacques
    CANCER RESEARCH, 2018, 78 (13)
  • [44] Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance
    Xin, Haisong
    Zhou, Chaoxi
    Wang, Guanglin
    Liu, Yan
    Zhang, Juan
    Liu, Youqiang
    Li, Baokun
    Zhang, Jianfeng
    Su, Mingming
    Li, Zhihan
    Wang, Guiying
    HELIYON, 2023, 9 (02)
  • [45] To Assess the Predictive and Prognostic Role of PD-L1 and CD8 Following Neoadjuvant Chemotherapy in Breast Cancer
    Pandey, Pinki
    Trivedi, Kapil
    Aggarwal, Roopak
    Dixit, Alok
    Yadav, Alka
    Agarwal, Savita
    Singh, Shailendra Pal
    Mittal, Kailash Kumar
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [46] PD-L1 and CD8+T cell evaluation in breast cancers and their correlation with clinicopathological parameters
    Kazmi, Sayher
    Shawana, Sumayyah
    Jamal, Nighat
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (07) : 1274 - 1279
  • [47] The Effects of The PD-1/PD-L1 Axis and Its Implications for Immunotherapy in Gastrointestinal Tract Cancers
    Cao, Xin
    Zhang, Jin-Ping
    Tu, Li-Ying
    Zou, Yun-Lian
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2024, 51 (08) : 1834 - 1847
  • [48] Immunoscore system combining CD8 and PD-1/PD-L1: A novel approach that predicts the clinical outcomes for cervical cancer
    Chen, Hong
    Xia, Bairong
    Zheng, Tongsen
    Lou, Ge
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2020, 35 (01) : 65 - 73
  • [49] Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy
    Chen, Junyu
    Zhong, Wenlong
    Yang, Meng
    Hou, Weibin
    Wang, Xiaofei
    Xia, Kun
    Yu, Hao
    Yang, Meihua
    Zhou, Bingkun
    Wang, Bo
    Huang, Jian
    Lin, Tianxin
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2657 - 2668
  • [50] Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy
    Junyu Chen
    Wenlong Zhong
    Meng Yang
    Weibin Hou
    Xiaofei Wang
    Kun Xia
    Hao Yu
    Meihua Yang
    Bingkun Zhou
    Bo Wang
    Jian Huang
    Tianxin Lin
    Cancer Immunology, Immunotherapy, 2021, 70 : 2657 - 2668
12345